Immunocompromised pediatric patients showed T-cell activity and humoral immunity against SARS-CoV-2
New coronavirus lingers in penis and could cause impotence
13 May 2021Knowledge gaps on opioid use after surgery offer opportunities for improving patient education
13 May 2021Immunocompromised pediatric patients showed T-cell activity and humoral immunity against SARS-CoV-2
According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children’s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.
